Follow
Maria Toki
Maria Toki
Verified email at yale.edu
Title
Cited by
Cited by
Year
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
J Wang, J Sun, LN Liu, DB Flies, X Nie, M Toki, J Zhang, C Song, M Zarr, ...
Nature medicine 25 (4), 656-666, 2019
5292019
Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis
I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ...
Clinical Cancer Research 25 (15), 4663-4673, 2019
2622019
A quantitative comparison of antibodies to programmed cell death 1 ligand 1
P Gaule, JW Smithy, M Toki, J Rehman, F Patell-Socha, D Cougot, ...
JAMA oncology 3 (2), 256-259, 2017
2022017
Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non–small cell lung cancer
F Villarroel-Espindola, X Yu, I Datar, N Mani, M Sanmamed, V Velcheti, ...
Clinical Cancer Research 24 (7), 1562-1573, 2018
1822018
High-plex predictive marker discovery for melanoma immunotherapy–treated patients using digital spatial profiling
MI Toki, CR Merritt, PF Wong, JW Smithy, HM Kluger, KN Syrigos, GT Ong, ...
Clinical Cancer Research 25 (18), 5503-5512, 2019
1392019
Multiplex quantitative analysis of tumor-infiltrating lymphocytes and immunotherapy outcome in metastatic melanoma
PF Wong, W Wei, JW Smithy, B Acs, MI Toki, KRM Blenman, D Zelterman, ...
Clinical Cancer Research 25 (8), 2442-2449, 2019
1232019
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
B Acs, V Pelekanou, Y Bai, S Martinez-Morilla, M Toki, SCY Leung, ...
Laboratory Investigation 99 (1), 107-117, 2019
1182019
B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes
M Altan, V Pelekanou, KA Schalper, M Toki, P Gaule, K Syrigos, ...
Clinical Cancer Research 23 (17), 5202-5209, 2017
1152017
Immune checkpoint inhibitor–associated pericarditis
M Altan, MI Toki, SN Gettinger, DE Carvajal-Hausdorf, J Zugazagoitia, ...
Journal of Thoracic Oncology 14 (6), 1102-1108, 2019
912019
Immune marker profiling and programmed death ligand 1 expression across NSCLC mutations
MI Toki, N Mani, JW Smithy, Y Liu, M Altan, B Wasserman, R Tuktamyshov, ...
Journal of Thoracic Oncology 13 (12), 1884-1896, 2018
892018
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Infection 49 (5), 889-905, 2021
872021
Oncogenic EGFR represses the TET1 DNA demethylase to induce silencing of tumor suppressors in cancer cells
M Forloni, R Gupta, A Nagarajan, LS Sun, Y Dong, V Pirazzoli, M Toki, ...
Cell reports 16 (2), 457-471, 2016
612016
Quantitative assessment of CMTM6 in the tumor microenvironment and association with response to PD-1 pathway blockade in advanced-stage Non–Small cell lung cancer
J Zugazagoitia, Y Liu, M Toki, J McGuire, FS Ahmed, BS Henick, R Gupta, ...
Journal of Thoracic Oncology 14 (12), 2084-2096, 2019
572019
Proof of the quantitative potential of immunofluorescence by mass spectrometry
MI Toki, F Cecchi, T Hembrough, KN Syrigos, DL Rimm
Laboratory Investigation 97 (3), 329-334, 2017
482017
Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
M Altan, KM Kidwell, V Pelekanou, DE Carvajal-Hausdorf, KA Schalper, ...
NPJ Breast Cancer 4 (1), 40, 2018
432018
Biomarker discovery in patients with immunotherapy-treated melanoma with imaging mass cytometry
S Martinez-Morilla, F Villarroel-Espindola, PF Wong, MI Toki, TN Aung, ...
Clinical Cancer Research 27 (7), 1987-1996, 2021
422021
The value of open-source clinical science in pandemic response: lessons from ISARIC
A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ...
The Lancet infectious diseases 21 (12), 1623-1624, 2021
332021
ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19
M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ...
Scientific data 9 (1), 454, 2022
312022
The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision making
MI Toki, K Harrington, KN Syrigos
Lung Cancer 146, 127-133, 2020
252020
EGFR-GRB2 protein colocalization is a prognostic factor unrelated to overall EGFR expression or EGFR mutation in lung adenocarcinoma
MI Toki, DE Carvajal-Hausdorf, M Altan, J McLaughlin, B Henick, ...
Journal of Thoracic Oncology 11 (11), 1901-1911, 2016
192016
The system can't perform the operation now. Try again later.
Articles 1–20